Literature DB >> 22471448

Dietary turmeric potentially reduces the risk of cancer.

Amanda Hutchins-Wolfbrandt1, Anahita M Mistry.   

Abstract

Turmeric, a plant rhizome that is often dried, ground and used as a cooking spice, has also been used medicinally for several thousand years. Curcumin, the phytochemical that gives turmeric its golden color, is responsible for most of the therapeutic effects of turmeric. In recent years curcumin has been studied for its effects on chronic diseases such as diabetes, Alzheimer's, and cancer. Though many researchers are investigating turmeric/curcumin in cancer therapy, there is little epidemiologic information on the effects of turmeric consumption. With limited availability of pharmacologic interventions in many areas of the world, use of turmeric in the diet may help to alleviate some of the disease burden through prevention. Here we provide a brief overview of turmeric consumption in different parts of the world, cancer rates in those regions, possible biochemical mechanisms by which turmeric acts and practical recommendations based on the information available.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22471448

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders.

Authors:  Aiguo Wu; Emily E Noble; Ethika Tyagi; Zhe Ying; Yumei Zhuang; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta       Date:  2014-12-27

2.  In Vitro Antioxidant Properties of Dichloromethanolic Leaf Extract of Gnidia glauca (Fresen) as a Promising Antiobesity Drug.

Authors:  Wycliffe Arika; Cromwell Mwiti Kibiti; Joan Murugi Njagi; Mathew Piero Ngugi
Journal:  J Evid Based Integr Med       Date:  2019 Jan-Dec

Review 3.  The Impact of Oxidative Stress in Human Pathology: Focus on Gastrointestinal Disorders.

Authors:  Rosa Vona; Lucia Pallotta; Martina Cappelletti; Carola Severi; Paola Matarrese
Journal:  Antioxidants (Basel)       Date:  2021-01-30

Review 4.  Review of Under-Recognized Adjunctive Therapies for Cancer.

Authors:  Mary E Money; Carolyn M Matthews; Jocelyn Tan-Shalaby
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

5.  Effect of curcumin on the interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts.

Authors:  Jeong Hee Hong; Gilho Lee; Han Yong Choi
Journal:  Korean J Urol       Date:  2015-08-31

6.  Insights from zebrafish and mouse models on the activity and safety of ar-turmerone as a potential drug candidate for the treatment of epilepsy.

Authors:  Adriana Monserrath Orellana-Paucar; Tatiana Afrikanova; Joice Thomas; Yelaman K Aibuldinov; Wim Dehaen; Peter A M de Witte; Camila V Esguerra
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.